nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.623	1	CiPCiCtD
Telaprevir—ALB—Acitretin—psoriasis	0.0405	0.192	CbGbCtD
Telaprevir—ALB—Mycophenolate mofetil—psoriasis	0.019	0.0899	CbGbCtD
Telaprevir—ALB—Prednisone—psoriasis	0.0152	0.0719	CbGbCtD
Telaprevir—CELA1—skin epidermis—psoriasis	0.0137	0.308	CbGeAlD
Telaprevir—CYP3A4—Calcitriol—psoriasis	0.0133	0.0631	CbGbCtD
Telaprevir—CYP3A4—Methoxsalen—psoriasis	0.0104	0.0491	CbGbCtD
Telaprevir—ABCB1—Mycophenolate mofetil—psoriasis	0.00992	0.047	CbGbCtD
Telaprevir—CTSK—skeletal joint—psoriasis	0.0094	0.212	CbGeAlD
Telaprevir—ABCB1—Betamethasone—psoriasis	0.00851	0.0403	CbGbCtD
Telaprevir—ABCB1—Prednisolone—psoriasis	0.0084	0.0398	CbGbCtD
Telaprevir—ABCB1—Hydrocortisone—psoriasis	0.00796	0.0377	CbGbCtD
Telaprevir—ABCB1—Prednisone—psoriasis	0.00793	0.0376	CbGbCtD
Telaprevir—ALB—Methotrexate—psoriasis	0.00761	0.0361	CbGbCtD
Telaprevir—ABCB1—Cyclosporine—psoriasis	0.00752	0.0356	CbGbCtD
Telaprevir—CYP3A4—Cholecalciferol—psoriasis	0.00686	0.0325	CbGbCtD
Telaprevir—CTSS—synovial membrane of synovial joint—psoriasis	0.00626	0.141	CbGeAlD
Telaprevir—CYP3A4—Triamcinolone—psoriasis	0.00594	0.0282	CbGbCtD
Telaprevir—CYP3A4—Mycophenolate mofetil—psoriasis	0.00594	0.0282	CbGbCtD
Telaprevir—CYP3A4—Betamethasone—psoriasis	0.0051	0.0242	CbGbCtD
Telaprevir—CYP3A4—Prednisolone—psoriasis	0.00503	0.0239	CbGbCtD
Telaprevir—ABCB1—Dexamethasone—psoriasis	0.00495	0.0235	CbGbCtD
Telaprevir—CYP3A4—Hydrocortisone—psoriasis	0.00477	0.0226	CbGbCtD
Telaprevir—CYP3A4—Prednisone—psoriasis	0.00475	0.0225	CbGbCtD
Telaprevir—CYP3A4—Cyclosporine—psoriasis	0.00451	0.0214	CbGbCtD
Telaprevir—CELA1—skin of body—psoriasis	0.00423	0.0954	CbGeAlD
Telaprevir—ABCB1—Methotrexate—psoriasis	0.00398	0.0189	CbGbCtD
Telaprevir—ORM1—vertebral column—psoriasis	0.00391	0.0881	CbGeAlD
Telaprevir—CYP3A4—Dexamethasone—psoriasis	0.00297	0.0141	CbGbCtD
Telaprevir—CMA1—skin of body—psoriasis	0.0022	0.0497	CbGeAlD
Telaprevir—CTSK—skin of body—psoriasis	0.00142	0.032	CbGeAlD
Telaprevir—CTSS—skin of body—psoriasis	0.00124	0.028	CbGeAlD
Telaprevir—CTSK—tendon—psoriasis	0.00108	0.0244	CbGeAlD
Telaprevir—CTSS—tendon—psoriasis	0.000947	0.0213	CbGeAlD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—JUN—psoriasis	0.000299	0.00636	CbGpPWpGaD
Telaprevir—CTSK—MHC class II antigen presentation—HLA-DRB1—psoriasis	0.000289	0.00615	CbGpPWpGaD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—NFKB1—psoriasis	0.000288	0.00612	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KIR2DS1—psoriasis	0.000286	0.00608	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—ITGAL—psoriasis	0.000258	0.00549	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—SOCS1—psoriasis	0.000255	0.00541	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ERAP1—psoriasis	0.000242	0.00513	CbGpPWpGaD
Telaprevir—CTSS—MHC class II antigen presentation—HLA-DRB1—psoriasis	0.000238	0.00506	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KIR2DS1—psoriasis	0.000236	0.00501	CbGpPWpGaD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-C—psoriasis	0.000231	0.00491	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—DDX58—psoriasis	0.000221	0.00471	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—NFKBIA—psoriasis	0.000213	0.00452	CbGpPWpGaD
Telaprevir—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000212	0.00451	CbGpPWpGaD
Telaprevir—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00021	0.00447	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERAP1—psoriasis	0.000199	0.00423	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—TYK2—psoriasis	0.000195	0.00415	CbGpPWpGaD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-E—psoriasis	0.000192	0.00407	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—REN—psoriasis	0.000187	0.00397	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—DDX58—psoriasis	0.000182	0.00388	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—NFKBIA—psoriasis	0.000175	0.00372	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—TYK2—psoriasis	0.000174	0.0037	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Acitretin—psoriasis	0.000167	0.00223	CcSEcCtD
Telaprevir—Fatigue—Acitretin—psoriasis	0.000167	0.00223	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000167	0.00223	CcSEcCtD
Telaprevir—Blood uric acid increased—Methotrexate—psoriasis	0.000163	0.00217	CcSEcCtD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000162	0.00344	CbGpPWpGaD
Telaprevir—Infestation NOS—Cyclosporine—psoriasis	0.000162	0.00216	CcSEcCtD
Telaprevir—Infestation—Cyclosporine—psoriasis	0.000162	0.00216	CcSEcCtD
Telaprevir—Dizziness—Methoxsalen—psoriasis	0.000162	0.00216	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—ITGAL—psoriasis	0.000161	0.00343	CbGpPWpGaD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—SOCS1—psoriasis	0.00016	0.0034	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00016	0.0034	CbGpPWpGaD
Telaprevir—Infestation—Mycophenolate mofetil—psoriasis	0.000158	0.00211	CcSEcCtD
Telaprevir—Infestation NOS—Mycophenolate mofetil—psoriasis	0.000158	0.00211	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000158	0.0021	CcSEcCtD
Telaprevir—Asthenia—Calcitriol—psoriasis	0.000156	0.00209	CcSEcCtD
Telaprevir—Malnutrition—Mycophenolic acid—psoriasis	0.000156	0.00209	CcSEcCtD
Telaprevir—Pruritus—Calcitriol—psoriasis	0.000154	0.00206	CcSEcCtD
Telaprevir—Rash—Methoxsalen—psoriasis	0.000154	0.00206	CcSEcCtD
Telaprevir—Dermatitis—Methoxsalen—psoriasis	0.000154	0.00206	CcSEcCtD
Telaprevir—Urticaria—Acitretin—psoriasis	0.000154	0.00206	CcSEcCtD
Telaprevir—Hepatobiliary disease—Cyclosporine—psoriasis	0.000153	0.00204	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—IFIH1—psoriasis	0.000152	0.00324	CbGpPWpGaD
Telaprevir—Infection—Hydroxyurea—psoriasis	0.000151	0.00202	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—REL—psoriasis	0.000151	0.0032	CbGpPWpGaD
Telaprevir—Nervous system disorder—Hydroxyurea—psoriasis	0.000149	0.00199	CcSEcCtD
Telaprevir—Hepatobiliary disease—Mycophenolate mofetil—psoriasis	0.000149	0.00199	CcSEcCtD
Telaprevir—Diarrhoea—Calcitriol—psoriasis	0.000149	0.00199	CcSEcCtD
Telaprevir—Thrombocytopenia—Hydroxyurea—psoriasis	0.000149	0.00199	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—HCAR2—psoriasis	0.000148	0.00314	CbGpPWpGaD
Telaprevir—Skin disorder—Hydroxyurea—psoriasis	0.000148	0.00197	CcSEcCtD
Telaprevir—CTSK—Immune System—ERAP1—psoriasis	0.000147	0.00311	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—ICAM1—psoriasis	0.000146	0.00309	CbGpPWpGaD
Telaprevir—Nausea—Methoxsalen—psoriasis	0.000145	0.00194	CcSEcCtD
Telaprevir—Hypokalaemia—Dexamethasone—psoriasis	0.000145	0.00194	CcSEcCtD
Telaprevir—Hypokalaemia—Betamethasone—psoriasis	0.000145	0.00194	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—HLA-C—psoriasis	0.000144	0.00307	CbGpPWpGaD
Telaprevir—Anaemia—Mycophenolic acid—psoriasis	0.000144	0.00193	CcSEcCtD
Telaprevir—Infestation—Hydrocortisone—psoriasis	0.000144	0.00192	CcSEcCtD
Telaprevir—Infestation NOS—Hydrocortisone—psoriasis	0.000144	0.00192	CcSEcCtD
Telaprevir—CTSS—Toll-Like Receptors Cascades—TYK2—psoriasis	0.000143	0.00305	CbGpPWpGaD
Telaprevir—Urinary tract disorder—Cyclosporine—psoriasis	0.000143	0.00191	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—TNFAIP3—psoriasis	0.000143	0.00303	CbGpPWpGaD
Telaprevir—Urethral disorder—Cyclosporine—psoriasis	0.000142	0.0019	CcSEcCtD
Telaprevir—CTSK—Toll-Like Receptors Cascades—JUN—psoriasis	0.000141	0.003	CbGpPWpGaD
Telaprevir—Syncope—Mycophenolic acid—psoriasis	0.00014	0.00187	CcSEcCtD
Telaprevir—Urinary tract disorder—Mycophenolate mofetil—psoriasis	0.00014	0.00187	CcSEcCtD
Telaprevir—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.000139	0.00186	CcSEcCtD
Telaprevir—Asthenia—Acitretin—psoriasis	0.000139	0.00186	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—HLA-C—psoriasis	0.000139	0.00295	CbGpPWpGaD
Telaprevir—Urethral disorder—Mycophenolate mofetil—psoriasis	0.000139	0.00185	CcSEcCtD
Telaprevir—Vomiting—Calcitriol—psoriasis	0.000138	0.00185	CcSEcCtD
Telaprevir—Rash—Calcitriol—psoriasis	0.000137	0.00183	CcSEcCtD
Telaprevir—Loss of consciousness—Mycophenolic acid—psoriasis	0.000137	0.00183	CcSEcCtD
Telaprevir—Dermatitis—Calcitriol—psoriasis	0.000137	0.00183	CcSEcCtD
Telaprevir—Pruritus—Acitretin—psoriasis	0.000137	0.00183	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—STAT3—psoriasis	0.000137	0.00291	CbGpPWpGaD
Telaprevir—Pruritus—Fluocinolone Acetonide—psoriasis	0.000137	0.00183	CcSEcCtD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-B—psoriasis	0.000137	0.0029	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—NFKB1—psoriasis	0.000136	0.00288	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ITGAL—psoriasis	0.000133	0.00282	CbGpPWpGaD
Telaprevir—Diarrhoea—Acitretin—psoriasis	0.000133	0.00177	CcSEcCtD
Telaprevir—Eye disorder—Mycophenolate mofetil—psoriasis	0.000132	0.00177	CcSEcCtD
Telaprevir—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000132	0.00177	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000132	0.00176	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000131	0.00175	CcSEcCtD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000131	0.00279	CbGpPWpGaD
Telaprevir—Fatigue—Hydroxyurea—psoriasis	0.000131	0.00175	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—ICAM1—psoriasis	0.00013	0.00276	CbGpPWpGaD
Telaprevir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00013	0.00275	CbGpPWpGaD
Telaprevir—Nausea—Calcitriol—psoriasis	0.000129	0.00173	CcSEcCtD
Telaprevir—CTSK—Immune System—DDX58—psoriasis	0.000129	0.00274	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TAGAP—psoriasis	0.000128	0.00273	CbGpPWpGaD
Telaprevir—Dizziness—Acitretin—psoriasis	0.000128	0.00171	CcSEcCtD
Telaprevir—Dizziness—Fluocinolone Acetonide—psoriasis	0.000128	0.00171	CcSEcCtD
Telaprevir—Infection—Mycophenolic acid—psoriasis	0.000127	0.00169	CcSEcCtD
Telaprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-A—psoriasis	0.000126	0.00269	CbGpPWpGaD
Telaprevir—Malnutrition—Cyclosporine—psoriasis	0.000126	0.00169	CcSEcCtD
Telaprevir—Hypokalaemia—Prednisone—psoriasis	0.000126	0.00169	CcSEcCtD
Telaprevir—Renal failure acute—Methotrexate—psoriasis	0.000126	0.00168	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—IFIH1—psoriasis	0.000126	0.00267	CbGpPWpGaD
Telaprevir—Shock—Mycophenolic acid—psoriasis	0.000125	0.00167	CcSEcCtD
Telaprevir—Nervous system disorder—Mycophenolic acid—psoriasis	0.000125	0.00167	CcSEcCtD
Telaprevir—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000125	0.00167	CcSEcCtD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000125	0.00265	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—REL—psoriasis	0.000124	0.00264	CbGpPWpGaD
Telaprevir—Skin disorder—Mycophenolic acid—psoriasis	0.000124	0.00165	CcSEcCtD
Telaprevir—Dysgeusia—Cyclosporine—psoriasis	0.000124	0.00165	CcSEcCtD
Telaprevir—Malnutrition—Mycophenolate mofetil—psoriasis	0.000123	0.00165	CcSEcCtD
Telaprevir—Vomiting—Acitretin—psoriasis	0.000123	0.00165	CcSEcCtD
Telaprevir—Vomiting—Fluocinolone Acetonide—psoriasis	0.000123	0.00164	CcSEcCtD
Telaprevir—Rash—Acitretin—psoriasis	0.000122	0.00163	CcSEcCtD
Telaprevir—Dermatitis—Acitretin—psoriasis	0.000122	0.00163	CcSEcCtD
Telaprevir—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000122	0.00259	CbGpPWpGaD
Telaprevir—Rash—Fluocinolone Acetonide—psoriasis	0.000122	0.00163	CcSEcCtD
Telaprevir—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000122	0.00163	CcSEcCtD
Telaprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000121	0.00257	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERAP1—psoriasis	0.000121	0.00256	CbGpPWpGaD
Telaprevir—Dysgeusia—Mycophenolate mofetil—psoriasis	0.000121	0.00161	CcSEcCtD
Telaprevir—Eye disorder—Hydrocortisone—psoriasis	0.00012	0.00161	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—HLA-E—psoriasis	0.00012	0.00255	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HLA-C—psoriasis	0.000119	0.00253	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—TNFAIP3—psoriasis	0.000118	0.0025	CbGpPWpGaD
Telaprevir—Anaemia—Cyclosporine—psoriasis	0.000117	0.00156	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—ACE—psoriasis	0.000117	0.00248	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—JUN—psoriasis	0.000116	0.00247	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HLA-E—psoriasis	0.000115	0.00245	CbGpPWpGaD
Telaprevir—Nausea—Acitretin—psoriasis	0.000115	0.00154	CcSEcCtD
Telaprevir—Nausea—Fluocinolone Acetonide—psoriasis	0.000115	0.00153	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—HLA-C—psoriasis	0.000114	0.00243	CbGpPWpGaD
Telaprevir—Anaemia—Mycophenolate mofetil—psoriasis	0.000114	0.00152	CcSEcCtD
Telaprevir—Malnutrition—Hydrocortisone—psoriasis	0.000112	0.0015	CcSEcCtD
Telaprevir—CTSS—Toll-Like Receptors Cascades—NFKB1—psoriasis	0.000112	0.00237	CbGpPWpGaD
Telaprevir—Syncope—Mycophenolate mofetil—psoriasis	0.00011	0.00148	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.00011	0.00147	CcSEcCtD
Telaprevir—Fatigue—Mycophenolic acid—psoriasis	0.00011	0.00147	CcSEcCtD
Telaprevir—Asthenia—Hydroxyurea—psoriasis	0.000109	0.00146	CcSEcCtD
Telaprevir—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.000108	0.00145	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—ICAM1—psoriasis	0.000107	0.00227	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000107	0.00143	CcSEcCtD
Telaprevir—CTSS—Immune System—DDX58—psoriasis	0.000106	0.00226	CbGpPWpGaD
Telaprevir—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.000104	0.00139	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000104	0.00139	CcSEcCtD
Telaprevir—Diarrhoea—Hydroxyurea—psoriasis	0.000104	0.00139	CcSEcCtD
Telaprevir—Dysgeusia—Triamcinolone—psoriasis	0.000103	0.00138	CcSEcCtD
Telaprevir—Syncope—Prednisolone—psoriasis	0.000103	0.00138	CcSEcCtD
Telaprevir—Eye disorder—Betamethasone—psoriasis	0.000103	0.00137	CcSEcCtD
Telaprevir—Eye disorder—Dexamethasone—psoriasis	0.000103	0.00137	CcSEcCtD
Telaprevir—Infection—Cyclosporine—psoriasis	0.000102	0.00137	CcSEcCtD
Telaprevir—Nervous system disorder—Cyclosporine—psoriasis	0.000101	0.00135	CcSEcCtD
Telaprevir—Loss of consciousness—Prednisolone—psoriasis	0.000101	0.00135	CcSEcCtD
Telaprevir—Thrombocytopenia—Cyclosporine—psoriasis	0.000101	0.00135	CcSEcCtD
Telaprevir—Syncope—Hydrocortisone—psoriasis	0.000101	0.00134	CcSEcCtD
Telaprevir—Dizziness—Hydroxyurea—psoriasis	0.000101	0.00134	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—SOCS1—psoriasis	0.0001	0.00213	CbGpPWpGaD
Telaprevir—Skin disorder—Cyclosporine—psoriasis	0.0001	0.00134	CcSEcCtD
Telaprevir—Infection—Mycophenolate mofetil—psoriasis	9.99e-05	0.00133	CcSEcCtD
Telaprevir—ALB—Hemostasis—SERPINB8—psoriasis	9.94e-05	0.00211	CbGpPWpGaD
Telaprevir—Eosinophilia—Methotrexate—psoriasis	9.92e-05	0.00132	CcSEcCtD
Telaprevir—Shock—Mycophenolate mofetil—psoriasis	9.89e-05	0.00132	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—HLA-E—psoriasis	9.87e-05	0.0021	CbGpPWpGaD
Telaprevir—Loss of consciousness—Hydrocortisone—psoriasis	9.86e-05	0.00132	CcSEcCtD
Telaprevir—Nervous system disorder—Mycophenolate mofetil—psoriasis	9.86e-05	0.00132	CcSEcCtD
Telaprevir—Thrombocytopenia—Mycophenolate mofetil—psoriasis	9.84e-05	0.00131	CcSEcCtD
Telaprevir—CTSK—Immune System—ITGAL—psoriasis	9.78e-05	0.00208	CbGpPWpGaD
Telaprevir—Skin disorder—Mycophenolate mofetil—psoriasis	9.77e-05	0.0013	CcSEcCtD
Telaprevir—Vomiting—Hydroxyurea—psoriasis	9.67e-05	0.00129	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—HLA-C—psoriasis	9.62e-05	0.00205	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—SOCS1—psoriasis	9.62e-05	0.00204	CbGpPWpGaD
Telaprevir—Rash—Hydroxyurea—psoriasis	9.59e-05	0.00128	CcSEcCtD
Telaprevir—Dermatitis—Hydroxyurea—psoriasis	9.58e-05	0.00128	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—IL13—psoriasis	9.56e-05	0.00203	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—IL6—psoriasis	9.56e-05	0.00203	CbGpPWpGaD
Telaprevir—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	9.49e-05	0.00202	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	9.49e-05	0.00127	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—HLA-E—psoriasis	9.48e-05	0.00202	CbGpPWpGaD
Telaprevir—Syncope—Triamcinolone—psoriasis	9.48e-05	0.00127	CcSEcCtD
Telaprevir—Loss of consciousness—Triamcinolone—psoriasis	9.29e-05	0.00124	CcSEcCtD
Telaprevir—Shock—Prednisolone—psoriasis	9.23e-05	0.00123	CcSEcCtD
Telaprevir—CTSK—Immune System—REL—psoriasis	9.14e-05	0.00194	CbGpPWpGaD
Telaprevir—Asthenia—Mycophenolic acid—psoriasis	9.14e-05	0.00122	CcSEcCtD
Telaprevir—Infection—Hydrocortisone—psoriasis	9.1e-05	0.00122	CcSEcCtD
Telaprevir—Nausea—Hydroxyurea—psoriasis	9.03e-05	0.00121	CcSEcCtD
Telaprevir—Pruritus—Mycophenolic acid—psoriasis	9.01e-05	0.0012	CcSEcCtD
Telaprevir—Shock—Hydrocortisone—psoriasis	9.01e-05	0.0012	CcSEcCtD
Telaprevir—Nervous system disorder—Hydrocortisone—psoriasis	8.98e-05	0.0012	CcSEcCtD
Telaprevir—Eye disorder—Prednisone—psoriasis	8.96e-05	0.0012	CcSEcCtD
Telaprevir—Infestation—Methotrexate—psoriasis	8.93e-05	0.00119	CcSEcCtD
Telaprevir—Infestation NOS—Methotrexate—psoriasis	8.93e-05	0.00119	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Cyclosporine—psoriasis	8.9e-05	0.00119	CcSEcCtD
Telaprevir—Skin disorder—Hydrocortisone—psoriasis	8.9e-05	0.00119	CcSEcCtD
Telaprevir—Fatigue—Cyclosporine—psoriasis	8.89e-05	0.00119	CcSEcCtD
Telaprevir—CTSK—Immune System—IFIH1—psoriasis	8.88e-05	0.00189	CbGpPWpGaD
Telaprevir—Stevens-Johnson syndrome—Methotrexate—psoriasis	8.85e-05	0.00118	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—IL17A—psoriasis	8.8e-05	0.00187	CbGpPWpGaD
Telaprevir—Diarrhoea—Mycophenolic acid—psoriasis	8.72e-05	0.00116	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	8.68e-05	0.00116	CcSEcCtD
Telaprevir—Syncope—Dexamethasone—psoriasis	8.6e-05	0.00115	CcSEcCtD
Telaprevir—Syncope—Betamethasone—psoriasis	8.6e-05	0.00115	CcSEcCtD
Telaprevir—Infection—Triamcinolone—psoriasis	8.57e-05	0.00114	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—HLA-B—psoriasis	8.54e-05	0.00182	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD8A—psoriasis	8.53e-05	0.00181	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—IL6—psoriasis	8.52e-05	0.00181	CbGpPWpGaD
Telaprevir—Shock—Triamcinolone—psoriasis	8.49e-05	0.00113	CcSEcCtD
Telaprevir—Hepatobiliary disease—Methotrexate—psoriasis	8.45e-05	0.00113	CcSEcCtD
Telaprevir—Loss of consciousness—Dexamethasone—psoriasis	8.43e-05	0.00113	CcSEcCtD
Telaprevir—Loss of consciousness—Betamethasone—psoriasis	8.43e-05	0.00113	CcSEcCtD
Telaprevir—Dizziness—Mycophenolic acid—psoriasis	8.42e-05	0.00113	CcSEcCtD
Telaprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.42e-05	0.00179	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HLA-C—psoriasis	8.42e-05	0.00179	CbGpPWpGaD
Telaprevir—Malnutrition—Prednisone—psoriasis	8.35e-05	0.00112	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—CAT—psoriasis	8.35e-05	0.00177	CbGpPWpGaD
Telaprevir—CTSK—Immune System—TNFAIP3—psoriasis	8.31e-05	0.00177	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—SOCS1—psoriasis	8.25e-05	0.00175	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HLA-B—psoriasis	8.2e-05	0.00174	CbGpPWpGaD
Telaprevir—Urticaria—Cyclosporine—psoriasis	8.19e-05	0.00109	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—IL12B—psoriasis	8.18e-05	0.00174	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—CRP—psoriasis	8.15e-05	0.00173	CbGpPWpGaD
Telaprevir—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	8.1e-05	0.00172	CbGpPWpGaD
Telaprevir—Vomiting—Mycophenolic acid—psoriasis	8.1e-05	0.00108	CcSEcCtD
Telaprevir—CTSS—Immune System—ITGAL—psoriasis	8.05e-05	0.00171	CbGpPWpGaD
Telaprevir—Rash—Mycophenolic acid—psoriasis	8.03e-05	0.00107	CcSEcCtD
Telaprevir—Dermatitis—Mycophenolic acid—psoriasis	8.03e-05	0.00107	CcSEcCtD
Telaprevir—Urticaria—Mycophenolate mofetil—psoriasis	7.99e-05	0.00107	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—HLA-E—psoriasis	7.99e-05	0.0017	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—APOE—psoriasis	7.97e-05	0.00169	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—SOCS1—psoriasis	7.92e-05	0.00168	CbGpPWpGaD
Telaprevir—Urinary tract disorder—Methotrexate—psoriasis	7.92e-05	0.00106	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.91e-05	0.00106	CcSEcCtD
Telaprevir—Fatigue—Hydrocortisone—psoriasis	7.9e-05	0.00105	CcSEcCtD
Telaprevir—Urethral disorder—Methotrexate—psoriasis	7.86e-05	0.00105	CcSEcCtD
Telaprevir—Infection—Dexamethasone—psoriasis	7.77e-05	0.00104	CcSEcCtD
Telaprevir—Infection—Betamethasone—psoriasis	7.77e-05	0.00104	CcSEcCtD
Telaprevir—Anaemia—Prednisone—psoriasis	7.72e-05	0.00103	CcSEcCtD
Telaprevir—Shock—Dexamethasone—psoriasis	7.7e-05	0.00103	CcSEcCtD
Telaprevir—Shock—Betamethasone—psoriasis	7.7e-05	0.00103	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—CCL20—psoriasis	7.68e-05	0.00163	CbGpPWpGaD
Telaprevir—Nervous system disorder—Betamethasone—psoriasis	7.67e-05	0.00103	CcSEcCtD
Telaprevir—Nervous system disorder—Dexamethasone—psoriasis	7.67e-05	0.00103	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—IL4—psoriasis	7.67e-05	0.00163	CbGpPWpGaD
Telaprevir—Thrombocytopenia—Dexamethasone—psoriasis	7.66e-05	0.00102	CcSEcCtD
Telaprevir—Thrombocytopenia—Betamethasone—psoriasis	7.66e-05	0.00102	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—HLA-A—psoriasis	7.6e-05	0.00162	CbGpPWpGaD
Telaprevir—Erythema multiforme—Methotrexate—psoriasis	7.58e-05	0.00101	CcSEcCtD
Telaprevir—Nausea—Mycophenolic acid—psoriasis	7.57e-05	0.00101	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—CRP—psoriasis	7.55e-05	0.00161	CbGpPWpGaD
Telaprevir—CTSS—Immune System—REL—psoriasis	7.53e-05	0.0016	CbGpPWpGaD
Telaprevir—Eye disorder—Methotrexate—psoriasis	7.49e-05	0.001	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	7.49e-05	0.00159	CbGpPWpGaD
Telaprevir—Syncope—Prednisone—psoriasis	7.49e-05	0.001	CcSEcCtD
Telaprevir—Urticaria—Prednisolone—psoriasis	7.45e-05	0.000995	CcSEcCtD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.44e-05	0.00158	CbGpPWpGaD
Telaprevir—Fatigue—Triamcinolone—psoriasis	7.44e-05	0.000993	CcSEcCtD
Telaprevir—Asthenia—Cyclosporine—psoriasis	7.39e-05	0.000988	CcSEcCtD
Telaprevir—Loss of consciousness—Prednisone—psoriasis	7.34e-05	0.00098	CcSEcCtD
Telaprevir—CTSS—Immune System—IFIH1—psoriasis	7.31e-05	0.00155	CbGpPWpGaD
Telaprevir—Pruritus—Cyclosporine—psoriasis	7.29e-05	0.000974	CcSEcCtD
Telaprevir—Urticaria—Hydrocortisone—psoriasis	7.28e-05	0.000972	CcSEcCtD
Telaprevir—CMA1—Metabolism of proteins—LEP—psoriasis	7.25e-05	0.00154	CbGpPWpGaD
Telaprevir—Asthenia—Mycophenolate mofetil—psoriasis	7.21e-05	0.000964	CcSEcCtD
Telaprevir—Pruritus—Mycophenolate mofetil—psoriasis	7.11e-05	0.00095	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.06e-05	0.000943	CcSEcCtD
Telaprevir—Diarrhoea—Cyclosporine—psoriasis	7.05e-05	0.000942	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—HLA-B—psoriasis	7.04e-05	0.0015	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD8A—psoriasis	7.02e-05	0.00149	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—IL6—psoriasis	7.01e-05	0.00149	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HLA-E—psoriasis	6.98e-05	0.00148	CbGpPWpGaD
Telaprevir—Malnutrition—Methotrexate—psoriasis	6.98e-05	0.000932	CcSEcCtD
Telaprevir—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.97e-05	0.00148	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HLA-DRB1—psoriasis	6.95e-05	0.00148	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HLA-C—psoriasis	6.93e-05	0.00147	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NFKBIA—psoriasis	6.89e-05	0.00146	CbGpPWpGaD
Telaprevir—Diarrhoea—Mycophenolate mofetil—psoriasis	6.88e-05	0.000919	CcSEcCtD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.88e-05	0.00146	CbGpPWpGaD
Telaprevir—Urticaria—Triamcinolone—psoriasis	6.85e-05	0.000915	CcSEcCtD
Telaprevir—CTSS—Immune System—TNFAIP3—psoriasis	6.85e-05	0.00145	CbGpPWpGaD
Telaprevir—Dysgeusia—Methotrexate—psoriasis	6.83e-05	0.000913	CcSEcCtD
Telaprevir—Dizziness—Cyclosporine—psoriasis	6.82e-05	0.00091	CcSEcCtD
Telaprevir—Infection—Prednisone—psoriasis	6.77e-05	0.000904	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—HLA-B—psoriasis	6.76e-05	0.00144	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Betamethasone—psoriasis	6.76e-05	0.000902	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Dexamethasone—psoriasis	6.76e-05	0.000902	CcSEcCtD
Telaprevir—Fatigue—Dexamethasone—psoriasis	6.75e-05	0.000901	CcSEcCtD
Telaprevir—Fatigue—Betamethasone—psoriasis	6.75e-05	0.000901	CcSEcCtD
Telaprevir—Shock—Prednisone—psoriasis	6.7e-05	0.000896	CcSEcCtD
Telaprevir—Nervous system disorder—Prednisone—psoriasis	6.68e-05	0.000893	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—ICAM1—psoriasis	6.67e-05	0.00142	CbGpPWpGaD
Telaprevir—Dizziness—Mycophenolate mofetil—psoriasis	6.65e-05	0.000888	CcSEcCtD
Telaprevir—ALB—Selenium Micronutrient Network—CAT—psoriasis	6.63e-05	0.00141	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—CRP—psoriasis	6.63e-05	0.00141	CbGpPWpGaD
Telaprevir—Skin disorder—Prednisone—psoriasis	6.62e-05	0.000884	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—NFKBIA—psoriasis	6.61e-05	0.00141	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.61e-05	0.00141	CbGpPWpGaD
Telaprevir—Asthenia—Hydrocortisone—psoriasis	6.57e-05	0.000878	CcSEcCtD
Telaprevir—Vomiting—Cyclosporine—psoriasis	6.55e-05	0.000875	CcSEcCtD
Telaprevir—Rash—Cyclosporine—psoriasis	6.5e-05	0.000868	CcSEcCtD
Telaprevir—Dermatitis—Cyclosporine—psoriasis	6.49e-05	0.000867	CcSEcCtD
Telaprevir—Pruritus—Hydrocortisone—psoriasis	6.48e-05	0.000866	CcSEcCtD
Telaprevir—Anaemia—Methotrexate—psoriasis	6.45e-05	0.000862	CcSEcCtD
Telaprevir—Vomiting—Mycophenolate mofetil—psoriasis	6.39e-05	0.000854	CcSEcCtD
Telaprevir—Rash—Mycophenolate mofetil—psoriasis	6.34e-05	0.000847	CcSEcCtD
Telaprevir—Dermatitis—Mycophenolate mofetil—psoriasis	6.33e-05	0.000846	CcSEcCtD
Telaprevir—Diarrhoea—Hydrocortisone—psoriasis	6.27e-05	0.000837	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—HLA-A—psoriasis	6.26e-05	0.00133	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CRP—psoriasis	6.22e-05	0.00132	CbGpPWpGaD
Telaprevir—Urticaria—Betamethasone—psoriasis	6.22e-05	0.00083	CcSEcCtD
Telaprevir—Urticaria—Dexamethasone—psoriasis	6.22e-05	0.00083	CcSEcCtD
Telaprevir—Dizziness—Prednisolone—psoriasis	6.2e-05	0.000828	CcSEcCtD
Telaprevir—Asthenia—Triamcinolone—psoriasis	6.19e-05	0.000827	CcSEcCtD
Telaprevir—Nausea—Cyclosporine—psoriasis	6.12e-05	0.000818	CcSEcCtD
Telaprevir—Pruritus—Triamcinolone—psoriasis	6.1e-05	0.000815	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—ICAM1—psoriasis	6.09e-05	0.0013	CbGpPWpGaD
Telaprevir—Dizziness—Hydrocortisone—psoriasis	6.06e-05	0.000809	CcSEcCtD
Telaprevir—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.02e-05	0.00128	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL10—psoriasis	5.98e-05	0.00127	CbGpPWpGaD
Telaprevir—Nausea—Mycophenolate mofetil—psoriasis	5.97e-05	0.000798	CcSEcCtD
Telaprevir—Rash—Prednisolone—psoriasis	5.91e-05	0.00079	CcSEcCtD
Telaprevir—Dermatitis—Prednisolone—psoriasis	5.91e-05	0.000789	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.9e-05	0.000788	CcSEcCtD
Telaprevir—Fatigue—Prednisone—psoriasis	5.88e-05	0.000785	CcSEcCtD
Telaprevir—CTSK—Immune System—SOCS1—psoriasis	5.83e-05	0.00124	CbGpPWpGaD
Telaprevir—Vomiting—Hydrocortisone—psoriasis	5.82e-05	0.000778	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—IL4—psoriasis	5.82e-05	0.00124	CbGpPWpGaD
Telaprevir—Rash—Hydrocortisone—psoriasis	5.78e-05	0.000771	CcSEcCtD
Telaprevir—Dermatitis—Hydrocortisone—psoriasis	5.77e-05	0.000771	CcSEcCtD
Telaprevir—CTSS—Immune System—HLA-E—psoriasis	5.75e-05	0.00122	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HLA-DRB1—psoriasis	5.72e-05	0.00122	CbGpPWpGaD
Telaprevir—Dizziness—Triamcinolone—psoriasis	5.7e-05	0.000762	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	5.7e-05	0.00121	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.69e-05	0.00121	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.68e-05	0.00121	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—NFKBIA—psoriasis	5.67e-05	0.00121	CbGpPWpGaD
Telaprevir—Infection—Methotrexate—psoriasis	5.66e-05	0.000756	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—TYK2—psoriasis	5.64e-05	0.0012	CbGpPWpGaD
Telaprevir—Asthenia—Dexamethasone—psoriasis	5.61e-05	0.00075	CcSEcCtD
Telaprevir—Asthenia—Betamethasone—psoriasis	5.61e-05	0.00075	CcSEcCtD
Telaprevir—Nervous system disorder—Methotrexate—psoriasis	5.59e-05	0.000746	CcSEcCtD
Telaprevir—Thrombocytopenia—Methotrexate—psoriasis	5.58e-05	0.000745	CcSEcCtD
Telaprevir—Nausea—Prednisolone—psoriasis	5.57e-05	0.000744	CcSEcCtD
Telaprevir—Pruritus—Betamethasone—psoriasis	5.54e-05	0.00074	CcSEcCtD
Telaprevir—Pruritus—Dexamethasone—psoriasis	5.54e-05	0.00074	CcSEcCtD
Telaprevir—Skin disorder—Methotrexate—psoriasis	5.53e-05	0.000739	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—ICAM1—psoriasis	5.49e-05	0.00117	CbGpPWpGaD
Telaprevir—Vomiting—Triamcinolone—psoriasis	5.48e-05	0.000732	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—NFKBIA—psoriasis	5.45e-05	0.00116	CbGpPWpGaD
Telaprevir—Nausea—Hydrocortisone—psoriasis	5.44e-05	0.000727	CcSEcCtD
Telaprevir—Rash—Triamcinolone—psoriasis	5.44e-05	0.000726	CcSEcCtD
Telaprevir—Dermatitis—Triamcinolone—psoriasis	5.43e-05	0.000726	CcSEcCtD
Telaprevir—Urticaria—Prednisone—psoriasis	5.41e-05	0.000723	CcSEcCtD
Telaprevir—Diarrhoea—Dexamethasone—psoriasis	5.35e-05	0.000715	CcSEcCtD
Telaprevir—Diarrhoea—Betamethasone—psoriasis	5.35e-05	0.000715	CcSEcCtD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.3e-05	0.00113	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.27e-05	0.00112	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—CRP—psoriasis	5.27e-05	0.00112	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.19e-05	0.0011	CbGpPWpGaD
Telaprevir—Dizziness—Betamethasone—psoriasis	5.17e-05	0.000691	CcSEcCtD
Telaprevir—Dizziness—Dexamethasone—psoriasis	5.17e-05	0.000691	CcSEcCtD
Telaprevir—CTSK—Immune System—CD8A—psoriasis	5.17e-05	0.0011	CbGpPWpGaD
Telaprevir—Nausea—Triamcinolone—psoriasis	5.12e-05	0.000684	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—CD4—psoriasis	5.1e-05	0.00108	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HLA-B—psoriasis	4.98e-05	0.00106	CbGpPWpGaD
Telaprevir—Vomiting—Betamethasone—psoriasis	4.98e-05	0.000665	CcSEcCtD
Telaprevir—Vomiting—Dexamethasone—psoriasis	4.98e-05	0.000665	CcSEcCtD
Telaprevir—Rash—Betamethasone—psoriasis	4.93e-05	0.000659	CcSEcCtD
Telaprevir—Rash—Dexamethasone—psoriasis	4.93e-05	0.000659	CcSEcCtD
Telaprevir—Dermatitis—Betamethasone—psoriasis	4.93e-05	0.000658	CcSEcCtD
Telaprevir—Dermatitis—Dexamethasone—psoriasis	4.93e-05	0.000658	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Methotrexate—psoriasis	4.92e-05	0.000657	CcSEcCtD
Telaprevir—Fatigue—Methotrexate—psoriasis	4.91e-05	0.000656	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—CD4—psoriasis	4.9e-05	0.00104	CbGpPWpGaD
Telaprevir—Asthenia—Prednisone—psoriasis	4.89e-05	0.000653	CcSEcCtD
Telaprevir—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	4.84e-05	0.00103	CbGpPWpGaD
Telaprevir—Pruritus—Prednisone—psoriasis	4.82e-05	0.000644	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.82e-05	0.00102	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CXCL8—psoriasis	4.81e-05	0.00102	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SOCS1—psoriasis	4.8e-05	0.00102	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.75e-05	0.00101	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.74e-05	0.00101	CbGpPWpGaD
Telaprevir—Diarrhoea—Prednisone—psoriasis	4.66e-05	0.000623	CcSEcCtD
Telaprevir—Nausea—Betamethasone—psoriasis	4.65e-05	0.000621	CcSEcCtD
Telaprevir—Nausea—Dexamethasone—psoriasis	4.65e-05	0.000621	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—TYK2—psoriasis	4.65e-05	0.000987	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IFNG—psoriasis	4.64e-05	0.000985	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HLA-A—psoriasis	4.61e-05	0.00098	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—JUN—psoriasis	4.57e-05	0.00097	CbGpPWpGaD
Telaprevir—Urticaria—Methotrexate—psoriasis	4.52e-05	0.000604	CcSEcCtD
Telaprevir—Dizziness—Prednisone—psoriasis	4.51e-05	0.000602	CcSEcCtD
Telaprevir—CTSK—Immune System—CRP—psoriasis	4.4e-05	0.000935	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NFKB1—psoriasis	4.4e-05	0.000934	CbGpPWpGaD
Telaprevir—Vomiting—Prednisone—psoriasis	4.33e-05	0.000579	CcSEcCtD
Telaprevir—Rash—Prednisone—psoriasis	4.3e-05	0.000574	CcSEcCtD
Telaprevir—Dermatitis—Prednisone—psoriasis	4.29e-05	0.000573	CcSEcCtD
Telaprevir—CTSS—Immune System—CD8A—psoriasis	4.26e-05	0.000905	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SOCS1—psoriasis	4.23e-05	0.000899	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—NFKB1—psoriasis	4.22e-05	0.000897	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HLA-DRB1—psoriasis	4.21e-05	0.000895	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CD4—psoriasis	4.2e-05	0.000893	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HLA-B—psoriasis	4.1e-05	0.000871	CbGpPWpGaD
Telaprevir—Asthenia—Methotrexate—psoriasis	4.09e-05	0.000546	CcSEcCtD
Telaprevir—Nausea—Prednisone—psoriasis	4.05e-05	0.000541	CcSEcCtD
Telaprevir—CTSK—Immune System—ICAM1—psoriasis	4.04e-05	0.000859	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD4—psoriasis	4.03e-05	0.000857	CbGpPWpGaD
Telaprevir—Pruritus—Methotrexate—psoriasis	4.03e-05	0.000538	CcSEcCtD
Telaprevir—CTSK—Immune System—NFKBIA—psoriasis	4.01e-05	0.000853	CbGpPWpGaD
Telaprevir—Diarrhoea—Methotrexate—psoriasis	3.9e-05	0.000521	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—NFKB1—psoriasis	3.86e-05	0.00082	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HLA-A—psoriasis	3.8e-05	0.000807	CbGpPWpGaD
Telaprevir—Dizziness—Methotrexate—psoriasis	3.77e-05	0.000503	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—JUN—psoriasis	3.76e-05	0.000799	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.69e-05	0.000784	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.68e-05	0.000783	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CRP—psoriasis	3.62e-05	0.00077	CbGpPWpGaD
Telaprevir—Vomiting—Methotrexate—psoriasis	3.62e-05	0.000484	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—NFKB1—psoriasis	3.62e-05	0.000769	CbGpPWpGaD
Telaprevir—Rash—Methotrexate—psoriasis	3.59e-05	0.00048	CcSEcCtD
Telaprevir—Dermatitis—Methotrexate—psoriasis	3.59e-05	0.000479	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—IFNG—psoriasis	3.52e-05	0.000748	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.51e-05	0.000746	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—NFKB1—psoriasis	3.48e-05	0.000739	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HLA-DRB1—psoriasis	3.47e-05	0.000737	CbGpPWpGaD
Telaprevir—Nausea—Methotrexate—psoriasis	3.38e-05	0.000452	CcSEcCtD
Telaprevir—CTSS—Immune System—ICAM1—psoriasis	3.33e-05	0.000708	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NFKBIA—psoriasis	3.3e-05	0.000702	CbGpPWpGaD
Telaprevir—CTSK—Immune System—TYK2—psoriasis	3.29e-05	0.000698	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.27e-05	0.000695	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—LEP—psoriasis	3.12e-05	0.000664	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—APOE—psoriasis	3.12e-05	0.000664	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IFNG—psoriasis	3.08e-05	0.000654	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.07e-05	0.000652	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	3.06e-05	0.000651	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—psoriasis	3e-05	0.000638	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TNF—psoriasis	3e-05	0.000638	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.98e-05	0.000633	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD4—psoriasis	2.97e-05	0.000632	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NFKBIA—psoriasis	2.91e-05	0.000618	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ITGAL—psoriasis	2.89e-05	0.000614	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.86e-05	0.000608	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IL6—psoriasis	2.76e-05	0.000586	CbGpPWpGaD
Telaprevir—CTSS—Immune System—TYK2—psoriasis	2.71e-05	0.000575	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.69e-05	0.000573	CbGpPWpGaD
Telaprevir—CTSK—Immune System—JUN—psoriasis	2.66e-05	0.000565	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.66e-05	0.000565	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—psoriasis	2.65e-05	0.000562	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NDUFA5—psoriasis	2.6e-05	0.000552	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NFKB1—psoriasis	2.56e-05	0.000544	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IFNG—psoriasis	2.53e-05	0.000538	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD4—psoriasis	2.45e-05	0.00052	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.42e-05	0.000515	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL6—psoriasis	2.42e-05	0.000515	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.41e-05	0.000513	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.38e-05	0.000507	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TYK2—psoriasis	2.38e-05	0.000507	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.3e-05	0.00049	CbGpPWpGaD
Telaprevir—CTSK—Immune System—STAT3—psoriasis	2.3e-05	0.000489	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—psoriasis	2.28e-05	0.000484	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NDUFA5—psoriasis	2.28e-05	0.000484	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IL6—psoriasis	2.27e-05	0.000483	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.26e-05	0.000481	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2S1—psoriasis	2.21e-05	0.00047	CbGpPWpGaD
Telaprevir—CTSS—Immune System—JUN—psoriasis	2.19e-05	0.000465	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.12e-05	0.00045	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NFKB1—psoriasis	2.11e-05	0.000448	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL8—psoriasis	2.08e-05	0.000441	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.02e-05	0.000429	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2S1—psoriasis	1.94e-05	0.000411	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—JUN—psoriasis	1.93e-05	0.00041	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.92e-05	0.000409	CbGpPWpGaD
Telaprevir—CTSS—Immune System—STAT3—psoriasis	1.89e-05	0.000403	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NFKB1—psoriasis	1.86e-05	0.000395	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—psoriasis	1.69e-05	0.000358	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STAT3—psoriasis	1.67e-05	0.000355	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—psoriasis	1.61e-05	0.000342	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.5e-05	0.000319	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.44e-05	0.000307	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NDUFA5—psoriasis	1.4e-05	0.000298	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.33e-05	0.000283	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—psoriasis	1.32e-05	0.000281	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.31e-05	0.000279	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—psoriasis	1.27e-05	0.000271	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2S1—psoriasis	1.19e-05	0.000253	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS2—psoriasis	1.19e-05	0.000252	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—psoriasis	1.17e-05	0.000248	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.16e-05	0.000246	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.12e-05	0.000239	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CARM1—psoriasis	1.08e-05	0.000229	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.01e-05	0.000214	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	9.91e-06	0.000211	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CARM1—psoriasis	9.45e-06	0.000201	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—psoriasis	6.86e-06	0.000146	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CAT—psoriasis	6.64e-06	0.000141	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CARM1—psoriasis	5.82e-06	0.000124	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CAT—psoriasis	5.81e-06	0.000124	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—psoriasis	5.19e-06	0.00011	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APOE—psoriasis	5.16e-06	0.00011	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APOE—psoriasis	4.52e-06	9.6e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARG—psoriasis	4.49e-06	9.55e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARG—psoriasis	3.93e-06	8.36e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CAT—psoriasis	3.58e-06	7.61e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APOE—psoriasis	2.78e-06	5.92e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARG—psoriasis	2.42e-06	5.15e-05	CbGpPWpGaD
